Monotax XP 500mg/62.5mg Injection
Marketer
Zydus Healthcare Limited
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Monotax XP 500mg/62.5mg Injection
Combiflox 500mg/62.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation and infection spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the medication's effects.
Primary Ingredients of Monotax XP 500mg/62.5mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Monotax XP 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Monotax XP 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monotax XP 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Monotax XP 500mg/62.5mg Injection:
Administering this medication will be handled by your physician or their qualified staff; please do not attempt self-medication.
How Monotax XP 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactum Injection (Monotax XP 500mg/62.5mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of alcohol and Monotax XP 500mg/62.5mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Monotax XP (500mg/62.5mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal to no harmful consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Monotax XP 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Monotax XP 500mg/62.5mg can reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Monotax XP 500mg/62.5mg Injection use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Monotax XP 500mg/62.5mg Injection cautiously; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Monotax XP 500mg/62.5mg Injection isn't advised for individuals with mild to moderate liver dysfunction.
What if you forget to take Monotax XP 500mg/62.5mg Injection :
Omit a scheduled dose of Monotax XP 500mg/62.5mg Injection? Seek your physician's advice.
Facts to Know About Monotax XP 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |


